Publications by authors named "Judy Shi"

Claim this Profile
F
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy.
Yosuke Sato, Cierra N Casson, Atsushi Matsuda, James I Kim, Judy Qiuju Shi, Shinji Iwasaki

Cancer Immunol Immunother· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies.
Elizabeth Carideo Cunniff, Yosuke Sato, Doanh Mai, Vicky A Appleman, Shinji Iwasaki, Atsushi Matsuda, Judy Shi, Masato Yoshikawa, Vaishali Shinde, Pu Shi

Cancer Res Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.
Junling Zhuang, Fazal Shirazi, Ram Kumar Singh, Isere Kuiatse, Hua Wang, Judy Qiuju Shi, Vaishali Shinde

Blood· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profiles.
Pu Shi, Mingxiang Liao, Bei-Ching Chuang, Robert Griffin, Judy Shi

Xenobiotica· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.
Marc L Hyer, Michael A Milhollen, Jeff Ciavarri, Paul Fleming, Tary Traore, Judy Shi

Nat Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines.
Denise L Driscoll, Arijit Chakravarty, Doug Bowman, Vaishali Shinde, Kerri Lasky, Judy Shi

PLoS One· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, Bradley Stringer, Mark G Qian

Mol Cancer Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis